Male, 72 years of age, type 2 diabetes, overweight secondary to binge eating disorder. Taking glipizide 20mg daily and metformin 1,000mg twice daily. Hypoglycemic unawareness. Not regularly checking glucose. Recent A1C 6.8%.

Risks of death varied depending on age, glycemic control and renal complications.

HbA1c and lipids show improved with high-intensity physical activity.

New study suggests triple therapy improves glycemic control.

Recent study suggests that compelling biomarkers may predict major adverse outcomes, including death, in diabetes.

Carbohydrate substitutes do not decrease heart disease risk.

Benefits of surgery result in substantially lower healthcare costs for diabetic patients.

Higher fat in midsection poses increased risk for gestational diabetes later in pregnancy.

New technique may lead to novel treatment options for type 1 diabetes patients.

The anti-inflammatory effects may interfere with immune responses.